Forty female patients with either primary anti-phospholipid syndrome (n = 26) or systemic lupus erythematosus (anti-phospholipid syndrome positive) (n = 14) were investigated for levels of factor XII, the presence of lupus anticoagulant and antibodies to cardiolipin, beta 2-glycoprotein I and factor XII. Twenty-one patients had a history of recurrent fetal loss (> 2, mean = 2.6). Lupus anticoagulant positivity showed a weak association with recurrent fetal loss (odds ratio = 1.1). While there was no association between the presence of antibodies to cardiolipin or beta 2-glycoprotein I with recurrent fetal loss, antibodies to factor XII showed a strong and statistically significant association (odds ratio = 5.4, P = 0.025)
Pregnancies in women with systemic lupus erythematosus are recognized to result in excessive fetal m...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
AIM: The present study was aimed to define the incidence of antiphospholipid antibodies of different...
Antibodies to factor XII (FXIIabs) have been demonstrated in some patients with the antiphospholipid...
Abstract Background Antiphospholipid syndrome (APS) has been often associated to RPL since 1980 and ...
Recurrent fetal losses indicate screening for antiphospholipid antibodies, especially after the thir...
The aim of the study – to study the spectrum of antiphospholipid antibodies in patients with fetal l...
Recurrent pregnancy loss is associated with anti-phospholipid antibodies (aPL), in particular in wo...
We examined the association between anticardiolipin antibodies, lupus anticoagulant, and the risk of...
In order to determine the role of different anti-phospholipid antibodies as an etiologic factor in r...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Lupus anticoagulant (LA) and anti-cardiolipin antibodies (ACAs) are acquired antiphospholipid antibo...
The relation among lupus anticoagulant (LAC), anticardiolipin antibodies (ACA), and repeated abortio...
The aim of this study was to examine whether the clinical features of antiphospholipid antibody synd...
The objective of this study was to perform a longitudinal follow-up of antinuclear antibodies (ANAs)...
Pregnancies in women with systemic lupus erythematosus are recognized to result in excessive fetal m...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
AIM: The present study was aimed to define the incidence of antiphospholipid antibodies of different...
Antibodies to factor XII (FXIIabs) have been demonstrated in some patients with the antiphospholipid...
Abstract Background Antiphospholipid syndrome (APS) has been often associated to RPL since 1980 and ...
Recurrent fetal losses indicate screening for antiphospholipid antibodies, especially after the thir...
The aim of the study – to study the spectrum of antiphospholipid antibodies in patients with fetal l...
Recurrent pregnancy loss is associated with anti-phospholipid antibodies (aPL), in particular in wo...
We examined the association between anticardiolipin antibodies, lupus anticoagulant, and the risk of...
In order to determine the role of different anti-phospholipid antibodies as an etiologic factor in r...
The Antiphospholipid antibody Syndrome (APS) is characterised by recurrent thromboembolic phenomena,...
Lupus anticoagulant (LA) and anti-cardiolipin antibodies (ACAs) are acquired antiphospholipid antibo...
The relation among lupus anticoagulant (LAC), anticardiolipin antibodies (ACA), and repeated abortio...
The aim of this study was to examine whether the clinical features of antiphospholipid antibody synd...
The objective of this study was to perform a longitudinal follow-up of antinuclear antibodies (ANAs)...
Pregnancies in women with systemic lupus erythematosus are recognized to result in excessive fetal m...
The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphosp...
AIM: The present study was aimed to define the incidence of antiphospholipid antibodies of different...